Bioelectrical Impedance Analysis for Perioperative Fluid Evaluation in Colorectal Cancer Surgery
Usefulness of Bioelectrical Impedance Analysis for Perioperative Fluid Evaluation and Complication Prediction in Oncological Patients Undergoing Colorectal Surgery
2 other identifiers
interventional
85
1 country
1
Brief Summary
This study evaluates the usefulness of bioelectrical impedance analysis (BIA) for perioperative fluid evaluation and prediction of postoperative complications in oncological patients undergoing colorectal surgery. Bioelectrical impedance analysis is used to assess body fluid status and body composition before and after surgery. The study aims to determine whether perioperative BIA measurements may contribute to improved assessment of fluid balance and early identification of patients at increased risk of postoperative complications. The study is conducted at the Institute of Oncology Ljubljana in patients undergoing colorectal surgery for oncological indications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable colorectal-cancer
Started Oct 2023
Typical duration for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedFirst Submitted
Initial submission to the registry
February 4, 2026
CompletedFirst Posted
Study publicly available on registry
February 11, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedJuly 10, 2026
February 1, 2026
2.2 years
February 4, 2026
July 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Participants With Postoperative Complications Within 30 Days After Colorectal Surgery
Postoperative complications will be identified from routine clinical documentation after colorectal surgery. The unit of measure will be the percentage of participants with at least one postoperative complication within 30 days after colorectal surgery.
Up to 30 days after colorectal surgery.
Secondary Outcomes (5)
Change From Baseline in Total Body Water Assessed by Bioelectrical Impedance Analysis
From preoperative baseline to postoperative assessment, up to 30 days after colorectal surgery.
Change From Baseline in Extracellular Water Assessed by Bioelectrical Impedance Analysis
From preoperative baseline to postoperative assessment, up to 30 days after colorectal surgery.
Change From Baseline in Intracellular Water Assessed by Bioelectrical Impedance Analysis
From preoperative baseline to postoperative assessment, up to 30 days after colorectal surgery.
Change From Baseline in Extracellular Water to Total Body Water Ratio Assessed by Bioelectrical Impedance Analysis
From preoperative baseline to postoperative assessment, up to 30 days after colorectal surgery.
Change From Baseline in Fat-Free Mass Assessed by Bioelectrical Impedance Analysis
From preoperative baseline to postoperative assessment, up to 30 days after colorectal surgery.
Study Arms (1)
Bioelectrical Impedance Analysis
EXPERIMENTALOncological patients undergoing colorectal surgery undergo perioperative bioelectrical impedance analysis (BIA) measurements to assess body fluid status and body composition. BIA results are evaluated in relation to postoperative complications and perioperative clinical outcomes.
Interventions
Bioelectrical impedance analysis (BIA) is performed perioperatively to assess body fluid status and body composition. BIA parameters are evaluated for their potential usefulness in perioperative fluid assessment and prediction of postoperative complications in oncological patients undergoing colorectal surgery.
Eligibility Criteria
You may qualify if:
- Adult patients aged 18 years or older.
- Patients with oncological disease undergoing colorectal surgery at the Institute of Oncology Ljubljana.
- Ability to undergo bioelectrical impedance analysis (BIA) measurements.
- Signed written informed consent.
You may not qualify if:
- Patients younger than 18 years.
- Patients unable to undergo BIA measurements.
- Patients with conditions that, in the investigator's opinion, make participation in the study unsuitable.
- Refusal to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2026
First Posted
February 11, 2026
Study Start
October 24, 2023
Primary Completion
December 31, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
July 10, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share